Brain scan study of ADHD effects from methylphenidate
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study uses brain imaging (MRI) to see how methylphenidate affects brain activity in people with ADHD. It may help doctors better understand how this medicine works and who benefits most.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are right-handed
- You are not pregnant and not breastfeeding
- You do not have a neurological condition (brain or nerve disorder)
- Your thinking or memory issues are due to ADHD, not another cause
- You can safely have an MRI (no MRI contraindications)
- You are not currently smoking
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if the medication methylphenidate (commonly used for ADHD) can help manage attention and behavior problems in people with KBG syndrome. Each person acts as their own test case to see if the drug works for them.
This Phase 4 study checks whether certain markers change in the brain/body when children with ADHD take methylphenidate (a stimulant). It also compares these markers with healthy children to better understand ADHD.
This study tests whether CNS stimulant medications can improve irritability and aggression in children with ADHD. It looks for factors that predict who will benefit most.
This Phase 3 study tests how methylphenidate affects brain signals and attention in adults with ADHD, and in adults with mood-related attention problems. It also includes healthy volunteers to compare brain responses during brain scanning.
This study looks at how the brain's electrical activity may predict whether a child with ADHD will respond well to methylphenidate (Ritalin). It aims to find biological markers that could help doctors choose the right treatment sooner.
This study looks at how ADHD medications and small head movements during brain scans affect attention. It may help researchers understand how these medicines work, which could improve ADHD care.
Hear when a new ADHD - Combined Type trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.